1Wiser W,Berger A.Practical management of chemotherapy-induced nausea and vomiting[J].Oncology (Williston Park),2005;19(5):637-45. 被引量：1
2Aapro M.Palonosetron is effective in preventing acute and delayed chemotherapy-induced nausea and vomiting in patients recieving highly emetogenic chemotherapy (HEC)[AbstractA-17] [J].Support Care Cancer,2003;11(6):391-7. 被引量：1
3Jordan K,Kasper C,Schmoll HJ.Chemotherapy-induced nausea and vomiting:current and new standards in the antiemetic prophylaxis and treatment[J].Eur J Cancer,2005;41(12):199-205. 被引量：1
4Roila F,Donati D,Tamberi S,et al.Delayed emesis:incidence,pattern,prognostic factors and optimal treatment[J].Support Care Cancer,2002;10(7):88-95. 被引量：1
5Dranitsaris G,Leung P,Ciotti R,et al.A multinational study to measure the value that patients with cancer place on improved emesis control following cisplatin chemotherapy[J].Pharmacoeconomics,2001;19(9):955-67. 被引量：1
3Seckl M J, Higgins T, Widmer F, et al. [D-Argl,D-Trp5,7,9, Leull]substance P:a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells [J]. Cancer Res,1997 Jan 1,57(1):51-54. 被引量：1
8Tang H,Wang J,Bai F. Positive correlation of osteopontin,cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer[J].CANCER INVESTIGATION,2008,(01):60-67. 被引量：1
9Saltz LB,Clarke S,Díaz-Rubio E. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:a randomized phase III study[J].Journal of Clinical Oncology,2008,(12):2013-2019. 被引量：1
10Van Cutsem E,Peeters M,Siena S. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer[J].Journal of Clinical Oncology,2007,(13):1658-1664. 被引量：1
